Smoking Cessation and E-cigarettes - UK - January 2019
Overview
 
What you need to know 
The smoking cessation category is estimated to have declined in value by 2% in 2018, from £148 million in 2017 to £145.2 million. The category has seen no breakthrough innovation in recent years, and continues to face competition from E-cigarettes. 

Despite the TPD (Tobacco Products Directive) putting restrictions on the vaping sector, the market is predicted to have enjoyed strong growth in value in 2018, reaching £282.7 million; an increase of 12% from £252.4 million in 2017. It remains a popular smoking cessation method, used by 84% of E-cigarette users who have/tried to quit smoking.

Products covered in this Report
This Report covers smoking cessation products as well as electronic cigarettes (henceforth referred to as E-cigarettes).

Smoking cessation products are defined as those products intended to assist and support smokers who are attempting to quit smoking. This includes NRTs (Nicotine Replacement Therapies) which deliver a measured dose of nicotine to a smoker that replaces the nicotine usually obtained from cigarettes.

E-cigarettes are defined as electronic inhalers, designed to stimulate and act as a substitute for tobacco. The majority deliver nicotine when inhaled.

Sales data for smoking cessation gum, tablets and patches is included in the Market Size and Forecast, Channels to Market and Market Share sections. However, due to the unavailability of data, E-cigarettes sales data has not been included in these sections, although an estimate of the value of the market has been provided.